Interactions between Effectors Linked to Serotonin Receptors
- 1 December 1998
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 861 (1) , 111-120
- https://doi.org/10.1111/j.1749-6632.1998.tb10181.x
Abstract
In general, there are two types of interactions between effector signaling pathways. “Homologous” interactions are those that occur within a receptor system to alter its own responsiveness, for example the loss of responsiveness (desensitization) that can occur upon agonist occupancy of a receptor. “Heterologous” interactions are those that occur between different receptor systems where the responsiveness of one receptor system is regulated (positively or negatively) by activation of another receptor system (i.e., “cross‐talk”). Many, if not all receptors, couple to multiple cellular effector pathways and alterations in the responsiveness of a receptor system can be effector pathway‐dependent which underscores the importance of studying each effector coupled to a receptor. Regulation of receptor system responsiveness, and consequently the efficacy of drugs, is a highly dynamic process. Perhaps by exploiting these interactions, new targets for pharmacotherapy may be uncovered which will provide for increased efficacy and specificity of drug action.Keywords
This publication has 12 references indexed in Scilit:
- Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor StimulusMolecular Pharmacology, 1998
- Up‐regulation of a constitutively active form of the β2‐adrenoceptor by sustained treatment with inverse agonists but not antagonistsFEBS Letters, 1996
- Characterization of a 5‐HT1B receptor on CHO cells: functional responses in the absence of radioligand bindingBritish Journal of Pharmacology, 1996
- In vitro and in vivo profile of SB 206553, a potent 5‐HT2C/5‐HT2B receptor antagonist with anxiolytic‐like propertiesBritish Journal of Pharmacology, 1996
- Hippocampal long-term depression: Arachidonic acid as a potential retrograde messengerNeuropharmacology, 1995
- Serotonin 5‐HT2C Receptor Stimulates Cyclic GMP Formation in Choroid PlexusJournal of Neurochemistry, 1995
- The 5-HT1CReceptorAnnals of the New York Academy of Sciences, 1990
- Arachidonic Acid Cascade and Signal TransductionJournal of Neurochemistry, 1990
- Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis.Proceedings of the National Academy of Sciences, 1990
- A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.Proceedings of the National Academy of Sciences, 1986